Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	33-42
Number of pages	10
Journal	Health Technology Assessment
Volume	15
Issue number	Supp 1
Publication status	Published - May 2011

Access to Document

@article{27d2132e48234b7597d4ab34d1d19b12,

title = "Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.",

author = "G Norman and S Rice and E Spackman and L Stirk and A Danso-Appiah and D Suh and S Palmer and A Eastwood",

year = "2011",

month = may,

language = "English",

volume = "15",

pages = "33--42",

journal = "Health Technology Assessment",

issn = "2046-4924",

publisher = "NHS National Institute for Health Research",

number = "Supp 1",

}

TY - JOUR

T1 - Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.

AU - Norman, G

AU - Rice, S

AU - Spackman, E

AU - Stirk, L

AU - Danso-Appiah, A

AU - Suh, D

AU - Palmer, S

AU - Eastwood, A

PY - 2011/5

Y1 - 2011/5

UR - http://www.scopus.com/inward/record.url?scp=84863517479&partnerID=8YFLogxK

M3 - Article

SN - 2046-4924

VL - 15

SP - 33

EP - 42

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - Supp 1

ER -